Neil Berkley compensation by year
AbCellera Biologics Summary Compensation Table · the one fiscal year held| Component | FY2021 |
|---|---|
| Salary | $194,129 |
| Bonus | $144,545 |
| Stock awards | $2,107,407 |
| Option awards | $2,099,231 |
| Non-equity incentive | $0 |
| Pension and deferred compensation | $0 |
| All other | $26,596 |
| Total | $4,571,909 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: AbCellera Biologics Inc. DEF 14A filed April 28, 2022, accession 0001140361-22-016463, and prior-year filings. Open the filing on EDGAR.
How this page was built: the AbCellera Biologics Inc. filed document, accession 0001140361-22-016463. Every figure is read from that document and cited to the page and table it appears in. Filed April 28, 2022.
Equity holdings
unvested awards at FY2021 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| RSU | 70,000 | $0 | — |
| RSU | 68,729 | $0 | — |
| Option | 108,272 | — | $14.55 |
| Option | 105,000 | — | $15.82 |
Per the Outstanding Equity Awards at Fiscal Year-End table in AbCellera Biologics Inc.'s FY2021 proxy; value at the fiscal year-end close, as the company printed it.
AbCellera Biologics’s named executive officers, FY2021
as the company reported each| Named executive officer | Role | FY2021 total |
|---|---|---|
| Carl Hansen | Chief Executive Officer | $9,116,252 |
| Neil Berkley · this page | Chief Business Officer | $4,571,909 |
| Andrew Booth | Chief Financial Officer | $4,313,387 |
| Veronique Lecault | Chief Operating Officer | $4,313,387 |
| Tryn Stimart | Chief Legal Officer, Chief Compl i ance Officer & Corporate Secretary | $3,063,678 |
The full AbCellera Biologics compensation record
free company briefThis page is one person within AbCellera Biologics's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the AbCellera Biologics proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are AbCellera Biologics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.